88422-82-6

Upstream product

• 64-04-0 phenethylamine 
• 3972-81-4 N-(β-phenylethyl)-3,4-dimethoxyphenylacetamide 
• 10313-60-7 3,4-dimethoxyphenylacetyl chloride 
• 107779-30-6 (3,4-dimethoxy-phenyl)-acetic acid-(2-cyclohexa-1,4-dienyl-ethylamide) 

Downstream Products

• 21965-92-4 1-(3',4'-dimethoxybenzyl)isoquinoline 
• 39971-69-2 (3,4-dimethoxyphenyl)(isoquinolin-1-yl)methanone 
• 70045-30-6 1-(3',4'-dimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline 
• 22988-16-5 1-(3',4'-dimethoxybenzyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline 

Relevant academic research and scientific papers

Inhibition of dopamine receptors by endogenous amines: Binding to striatal receptors and pharmacological effects on locomotor activity

Endogenous amine 1-benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ) derivatives are synthesized, and their activity for dopaminergic systems are evaluated in vitro and in vivo by receptor binding assay and pharmacological tests. It is proposed that 1BnTIQ d

Substituted isoquinolines and methods of using same

Novel substituted isoquinoline compounds are disclosed together with novel 2-phenylethylamides useful as precursors or intermediates for the production of the isoquinolines. The substituted isoquinolines exhibit activity in antagonizing the effects of platelet activating factor (PAF).